The effectiveness and underlying mechanisms of eye movement desensitisation and reprocessing (EMDR) for posttraumatic stress disorder in Timor Leste.
- Conditions
- Posttraumatic stress disorderMental Health - Anxiety
- Registration Number
- ACTRN12611000239965
- Lead Sponsor
- Murdoch University - School of Psychology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
(1) Exposure to traumatic events in Timor Leste.
(2) The traumatic event occured at least 3 months prior to study entry.
(3) Has symptoms consistent with PTSD.
(4) Timorese resident.
(5) Males and females.
(6) Willingness to participate in the study (informed consent procedure).
(7) The participant has a level of stability and support or is linked with a Timorese NGO health service.
(1) Deaf, Blind, or a history of serious eye disease.
(2) The participant is in an ongoing threatening situation.
(3) Suicidal intent.
(4) Problematic substance use.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms consistent with PTSD is measured with the Harvard Trauma Questionnaire (HTQ: a version translated to Tetun/Indonesian).[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.]
- Secondary Outcome Measures
Name Time Method Depression is measured by using the Hopkins Symptom Checklist (HSCL - 25)[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.];Anxiety, symptoms of general anxiety is measured by using the Hopkins Symptom Checklist (HSCL - 25).[Administered at 2 weeks pre-treatment, pre-treatment, 2 weeks post-treatment, and at 3-months post-treatment.];The distress related to the memory of the event targeted for processing is measured by the within session process measure of Subject Units of distress (SUDS).[Administered during all desensitisation sessions, 2 weeks post treatment, and at 3-months post-treatment.];Psychophysiological changes within session and across treatment.[Within the first and last active treatment session ongoing measures of heart rate (HR), heart rate variability (HRV), skin conductance (SC), and respiration rate (RR) will be recorded.]